Skip to main content
IKT $1.32 +1.54%
IKT logo
IKT · Inhibikase Therapeutics, Inc.
Track IKT — free
$1.32 +0.02 (+1.54%) At close · Nov 20 Q2 2024 earnings call transcript
Market Cap
$185.16M
Shares
140.27M
Volume · Nov 20 1.11M Avg daily vol (3M) 580.26K
All webcasts

Earnings call · FY2020 Q4

Inhibikase Therapeutics, Inc. (IKT) Q4 2020 Earnings Call

Concluded Apr 1, 2021
Apr 1, 2021
Period
FY2020 Q4
Runtime
—
Sources
2 artifacts
Revenue · derived Q4 $170,416
Net income · derived Q4 -$1.21M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document